The expression of TSC22D2 was reported to be significantly downregulated in colorectal cancer, while we found that the expression of TSC22D2 was significantly higher in pancreatic cancer tissues/cells compared to the normal tissues/cells using public databases and experiments. The gene discussed is TSC22D2; the disease is pancreatic neoplasm.